Sign In
Buy NCNA
$2.03
-0.0400 (-1.93%)
At Close: Jun 03, 2026
The Full Nerd ep. 135: Intel Comet Lake H and Ghost Canyon NUC reviews, ray traced Minecraft
12:00am, Thursday, 16'th Apr 2020
In this episode of The Full Nerd, we review Intel's new "Comet Lake H" 10th-gen Core processors for gaming laptops and its radical Ghost Canyon NUC, and explain what you need to know about the ray tra
Intel NUC 9 Extreme Kit Ghost Canyon Review: All Potential | Digital Trends
01:00pm, Wednesday, 15'th Apr 2020
Intel's NUC 9 Extreme Kit uses the company's Compute Element to squeeze modular design in a small footprint. It has potential, but it's far from perfect.
Intel Ghost Canyon NUC9i9QNX review: The first modular NUC heralds a new future for mini PCs
12:00am, Wednesday, 15'th Apr 2020
The latest Next Unit of Computing from Intel may be less compact than its predecessors, but this worthy sacrifice allows room for its intriguing, upgradeable design.
NuCana Provides Update on Impact of COVID-19 on Clinical Studies
08:01pm, Thursday, 02'nd Apr 2020
NuCana plc (NCNA) has been closely monitoring the potential impact of the COVID-19 pandemic on its operations and announced today an update on the status of its ongoing clinical studies. In order to
The audacity of power and fetishism of due process (2) - Vanguard News
12:38am, Sunday, 29'th Mar 2020
In the publication by the Vice-Chancellor, “Council received and considered C.P. No. 2019/20/3b, which contained the nominees for honorary...
The audacity of power and fetishism of due process (1) - Vanguard News
12:43am, Sunday, 22'nd Mar 2020
For everyone that cherishes the great University of Lagos and what it stands for in terms of swag, upward mobility, production of men and...
Intel Frost Canyon NUC (NUC 10i7FNHAA) Review: Big Win | Digital Trends
01:00pm, Saturday, 21'st Mar 2020
Intel's new Frost Canyon NUC (NUC 10i7FNHAA) pairs a 10th-gen Core i7 processor with a tiny PC puck design. The result is an excellent mini-PC for creators.
NuCana (NASDAQ:NCNA) Is In A Good Position To Deliver On Growth Plans
12:25pm, Wednesday, 18'th Mar 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
The HE150: Small Footprint, Big Possibilities – Channel Futures
04:50pm, Monday, 16'th Mar 2020
The HE150 brings enterprise-class computing where it could not easily go before.
Analysts Offer Insights on Healthcare Companies: Exelixis (NASDAQ: EXEL) and Nucana (NASDAQ: NCNA)
06:42pm, Friday, 13'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Exelixis (
EXEL
–
Research Report
) and Nucana (
NCNA
–
Research Report
) with bullish sentiments.
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
Ngige, Adamu, Ahmed ASUU to meet Thursday - Vanguard News
07:32am, Wednesday, 11'th Mar 2020
THE Minister of Labour and Employment, Chris Ngige has appealed to the ASUU to "reconsider its decision on the on-going strike..."
NuCana Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Business Update
08:02pm, Tuesday, 10'th Mar 2020
First Patients Dosed in Global Phase III Biliary Tract Cancer Study (NuTide:121) with Potential for Accelerated Approval Filing Numerous Clinical Data Announcements Expected in.
NuCana plc (NCNA) announced preliminary results from part one of the Phase II study of single-agent Acelarin in patients with platinum-resistant ovarian cancer (PRO-105). This part of the study compa
